SOURCE: Xtalks

Xtalks Webinars

September 29, 2015 07:00 ET

Top News Stories You Might have Missed From Xtalks

TORONTO, ON--(Marketwired - September 29, 2015) - Xtalks Provides Current Articles Daily in the Life Science Industry. Check out all our news stories here: Subscribe to our weekly newsletters for the latest Life Science News & Articles --

Novartis Launches an Affordable Medicines Initiative for Lower Income Countries --
(Sep 28) The global pharmaceutical developer, Novartis, announced their program -- Novartis Access -- which proposes to provide 15 medications to treat chronic conditions, at a lower cost to patients in low income countries.

New Colorectal Cancer Medication Approved By FDA --
(Sep 28) The US Food and Drug Administration (FDA) announced their approval of Lonsurf -- a combination of two drugs -- to treat advanced stage colorectal cancer.

Preventing Microbial Growth on Medical Implants Using an Antimicrobial Biofilm --
(Sep 25) A team of researchers at the French National Institute of Health and Medical Research (Inserm), Strasbourg University in France, have developed an antimicrobial biofilm to be used to keep medical implants sterile.

Could Bacteriophages Be the Next Antibiotic? --
(Sep 25) Biological Engineers at the Massachusetts Institute of Technology (MIT), have developed a simple method to customize bacteriophages -- viruses that attack bacteria -- to target specific pathogenic strains.

Update: Turing Pharma CEO Retracts 5000 Percent Drug Price Increase --
(Sep 24) Turing Pharma CEO, Martin Shkreli made waves earlier this week, when he announced he'd be increasing the price of their antiparasitic drug, Daraprim, from $13.50 to $750, per dose.

Monitoring Sickle Cell Disease Using a Smartphone App --
(Sep 24) E. (Sarah) Du, Ph.D, and assistant professor in the Department of Ocean and Mechanical Engineering in Florida Atlantic University's College of Engineering and Computer Science, is developing a novel sensor and smartphone app, designed to monitor patients with sickle cell disease.

Consumable Electronics: Smart Pills for the Future of Medicine --
(Sep 23) In the wake of the recent FDA approval of 3-D printed pills, and the ingestible drug monitoring device, the idea of approved "smart pills" is far from unimaginable.

Probiotic Treatment Effective in Reversing Cow's Milk Allergies in Infants --
(Sep 23) Researchers at the University of Chicago, Argonne National Laboratory, in collaboration with the University of Naples Federico II, in Italy, have shown that treating cow's milk-intolerant infants with a probiotic supplement, was successful in reversing the milk allergy.

Microbiosensor Developed To Detect Microbial Contamination in a Contact Lens Cases --
(Sep 22) Dr. Nishal Govindji-Bhatt, a post-doctoral research fellow at the University of Manchester in the UK, and his colleagues have developed a small bacterial sensing device -- a microbiosensor -- to allow contact lens wearers to know when to change their lenses

Tuberculosis Management Improved By Medication E-Reminders --
(Sep 22) A study of tuberculosis (TB) patients in China, found that sending e-reminders increased patient adherence to the prescribed medication schedule.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit
For information about hosting a webinar visit

Contact Information